What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Protein Targeting: How Cells Sort and Deliver Proteins

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

A typical human cell contains roughly 10 billion protein molecules at any given moment, yet fewer than half of these proteins perform their functions in the cytosol where they are synthesized. The remainder must travel to specific compartments—the nucleus, mitochondria, endoplasmic reticulum (ER), Golgi apparatus, lysosomes, peroxisomes, or the extracellular space—to carry out their roles. This directed delivery is not haphazard; it is a highly regulated process called protein targeting, the mechanism by which cells sort newly synthesized proteins and deliver them to their correct destinations.

What Is Protein Targeting?

Protein targeting is the coordinated set of molecular processes that ensures each protein reaches its correct subcellular location. The process begins during translation—the synthesis of a protein from messenger RNA (mRNA) by the ribosome—and continues until the protein arrives at its final destination, often undergoing folding and modifications along the way.

The fundamental challenge is this: all proteins are assembled from the same twenty amino acids on the same ribosomes, yet they must end up in vastly different environments. A protein destined for the nucleus must cross the nuclear envelope; one destined for the mitochondrion must cross two membranes; one destined for secretion must traverse the entire endomembrane system. Protein targeting solves this problem through a system of molecular "address tags" and complementary receptors that read those tags.

Why Protein Targeting Matters

Errors in protein targeting have severe consequences. Cystic fibrosis, for example, results from a mutation in the CFTR chloride channel that causes the protein to misfold and be retained in the ER instead of reaching the plasma membrane. Primary hyperoxaluria type 1 occurs when the enzyme alanine-glyoxylate aminotransferase is mistargeted to mitochondria instead of peroxisomes, leading to oxalate crystal deposition in the kidneys. Even in normal physiology, cells must constantly adjust protein distribution in response to signals—for instance, moving glucose transporters to the cell surface after a meal.

Beyond disease, protein targeting is essential for cellular organization. The ER contains enzymes for lipid synthesis and protein glycosylation; lysosomes contain acid hydrolases that would destroy the cytosol if released; mitochondria maintain their own genome and import hundreds of proteins from the cytosol. Without precise targeting, this compartmentalization collapses, and the cell cannot function.

Overview of the Targeting Process

Protein targeting can be broken down into four general steps:

Signal recognition: The nascent protein contains a signal sequence—a short stretch of amino acids—that encodes its destination.
Receptor binding: Cytosolic or membrane-bound receptors recognize the signal sequence.
Translocation: The protein is transported across or inserted into the target membrane through protein channels called translocons.
Signal removal and maturation: The signal sequence is often cleaved, and the protein folds into its functional conformation, sometimes with the help of Chaperone Protein machinery.

The Journey of a Protein: From Ribosome to Destination

To understand protein targeting, one must first understand where proteins are made. All protein synthesis begins in the cytosol, but the ribosome's location relative to the ER determines the protein's fate.

Synthesis on Free vs. Bound Ribosomes

Ribosomes exist in two populations within the cell: free ribosomes suspended in the cytosol and bound ribosomes attached to the cytoplasmic face of the rough ER. This distinction is not permanent—the same ribosome can switch between free and bound states depending on which mRNA it is translating.

Proteins synthesized on free ribosomes remain in the cytosol unless they carry specific targeting signals that direct them to mitochondria, chloroplasts (in plants), peroxisomes, or the nucleus. Proteins synthesized on bound ribosomes are destined for the ER lumen, the ER membrane, the Golgi apparatus, lysosomes, the plasma membrane, or secretion from the cell.

The decision of whether a ribosome becomes bound to the ER is made within the first 30–60 seconds of translation. If the nascent protein contains an ER signal sequence at its N-terminus, the ribosome is directed to the ER membrane. If not, translation continues in the cytosol.

Signal Sequences and Their Role

A signal sequence (also called a signal peptide) is a short, typically 15–30 amino acid stretch that directs a protein to a specific cellular location. These sequences are the "zip codes" of the cell. They are usually located at the N-terminus of the protein, though some are internal or at the C-terminus.

ER signal sequences share a common structure: a positively charged N-terminal region, a central hydrophobic core of 6–15 amino acids, and a short polar region near the cleavage site. Mitochondrial targeting signals are rich in positively charged arginine and lysine residues and form an amphipathic helix—one face hydrophobic, one face positively charged. Nuclear localization signals are typically short stretches of basic amino acids such as lysine and arginine.

The signal sequence is recognized by specific proteins that mediate the targeting process. For ER targeting, the signal sequence is recognized by the signal recognition particle (SRP). For mitochondrial targeting, it is recognized by cytosolic chaperones that deliver the protein to the mitochondrial surface.

Types of Protein Targeting

Protein targeting is broadly divided into two categories based on when targeting occurs relative to translation: co-translational and post-translational.

Co-translational Targeting to the ER

Co-translational targeting occurs while the protein is still being synthesized. This pathway is used for proteins destined for the ER, Golgi, lysosomes, plasma membrane, or secretion. The process begins when the ER signal sequence emerges from the ribosome:

SRP binding: The signal recognition particle (SRP) binds to the exposed signal sequence and pauses translation. This pause gives the ribosome–SRP complex time to reach the ER membrane.
SRP receptor interaction: The SRP–ribosome complex diffuses to the ER membrane, where SRP binds to the SRP receptor, an integral membrane protein.
GTP hydrolysis and transfer: Both SRP and its receptor hydrolyze GTP, causing SRP to release the signal sequence and dissociate. The ribosome then docks onto the translocon.
Translocation: The nascent polypeptide chain is threaded through the translocon channel into the ER lumen as translation resumes.
Signal cleavage: Once the protein enters the ER lumen, signal peptidase cleaves off the signal sequence.

The translocon, called the Sec61 complex in eukaryotes, forms a channel through the ER membrane. It opens like a pore, allowing the growing polypeptide chain to pass through while maintaining the permeability barrier of the ER membrane.

Post-translational Targeting to Mitochondria, Chloroplasts, and Nucleus

Post-translational targeting occurs after the protein has been fully synthesized in the cytosol. This pathway is used for proteins destined for mitochondria, chloroplasts, peroxisomes, and the nucleus.

Mitochondrial targeting: Proteins destined for mitochondria are synthesized on free ribosomes and released into the cytosol. They are kept in an unfolded state by cytosolic chaperones such as Hsp70. The mitochondrial targeting signal at the N-terminus is recognized by receptors on the mitochondrial outer membrane (TOM complex—translocase of the outer membrane). The protein is then passed to the TIM complex (translocase of the inner membrane) for import into the matrix. Import requires energy from ATP hydrolysis and the electrochemical gradient across the inner membrane.

Chloroplast targeting (in plants): Similar to mitochondrial targeting, chloroplast proteins are imported post-translationally through TOC and TIC complexes (translocon at the outer/inner chloroplast envelope). Chloroplast targeting signals are longer than mitochondrial signals and are often cleaved in two steps.

Nuclear targeting: Nuclear import is unique because the nucleus is separated from the cytosol by a double membrane perforated by nuclear pore complexes. Proteins destined for the nucleus contain a nuclear localization signal (NLS) that is recognized by importin proteins. The importin–protein complex is translocated through the nuclear pore complex in a process requiring the small GTPase Ran. Unlike mitochondrial or ER import, nuclear import does not require protein unfolding—proteins can pass through the pore in their fully folded state.

Targeting to Peroxisomes and Secretory Pathway

Peroxisomal targeting: Peroxisomes import proteins post-translationally. Most peroxisomal matrix proteins contain a peroxisomal targeting signal type 1 (PTS1), a C-terminal tripeptide sequence (typically serine-lysine-leucine, SKL). The receptor Pex5 recognizes PTS1 and delivers the protein to the peroxisomal membrane, where it is translocated through a dynamic pore. Remarkably, peroxisomes can import fully folded and even oligomeric proteins.

Secretory pathway: Proteins destined for secretion follow the ER–Golgi route. After entering the ER, they are packaged into COPII-coated vesicles that bud from the ER and fuse with the Golgi apparatus. Within the Golgi, proteins are modified—glycosylated, sulfated, and proteolytically processed—before being sorted into vesicles destined for the plasma membrane or lysosomes. This pathway is constitutive (continuous) in many cells but can be regulated, as in the case of insulin secretion from pancreatic beta cells.

The Molecular Machinery of Protein Targeting

The precision of protein targeting depends on a set of conserved molecular machines that recognize signals, mediate translocation, and ensure proper folding.

Signal Recognition Particle (SRP) and Its Receptor

The signal recognition particle is a ribonucleoprotein complex—a combination of protein and RNA. In mammals, SRP consists of six proteins (SRP9, SRP14, SRP19, SRP54, SRP68, SRP72) and a 7S RNA molecule. The SRP54 subunit contains the signal sequence binding pocket, a hydrophobic groove that accommodates the hydrophobic core of the ER signal sequence.

SRP has two critical functions: it binds the signal sequence as it emerges from the ribosome, and it arrests translation elongation. This elongation arrest is mediated by SRP9/SRP14, which bind the ribosome and pause translation at a specific point—typically when the nascent chain is about 70 amino acids long. This pause gives the ribosome–SRP complex time to diffuse to the ER membrane.

The SRP receptor is a heterodimer of two subunits, SRα and SRβ, embedded in the ER membrane. When SRP binds its receptor, both SRP and the receptor undergo GTP hydrolysis, triggering a conformational change that releases the signal sequence and transfers the ribosome to the translocon.

Translocon Complexes

The Sec61 translocon is the core channel for ER translocation. It is a heterotrimeric complex (Sec61α, Sec61β, Sec61γ) that forms a narrow pore through the ER membrane. The pore is normally closed by a plug domain; when the ribosome docks, the plug moves aside, allowing the polypeptide chain to pass.

The translocon is not a passive channel. It interacts with the ribosome, with chaperones in the ER lumen (such as BiP, a member of the Hsp70 family), and with enzymes that modify the nascent chain. For membrane proteins, the translocon also contains a lateral gate that allows hydrophobic transmembrane segments to partition into the lipid bilayer.

Mitochondria use analogous translocons: the TOM complex for the outer membrane and the TIM23 complex for the inner membrane. The TOM complex contains receptors (Tom20, Tom22, Tom70) that recognize different classes of mitochondrial precursor proteins. The TIM23 complex, together with the motor protein mtHsp70, drives protein import into the matrix.

Chaperones and Folding

Once a protein reaches its destination, it must fold into its native three-dimensional structure. This process is assisted by molecular chaperones—proteins that bind partially folded or unfolded polypeptides and prevent aggregation. In the ER, BiP binds hydrophobic patches on nascent proteins, facilitating their passage through the translocon and promoting folding. In mitochondria, mtHsp70 in the matrix pulls proteins through the TIM23 complex and assists their folding.

Chaperones are not just passive helpers; they are quality control agents. In the ER, misfolded proteins are recognized by the unfolded protein response, which upregulates chaperone expression and, if the protein cannot be fixed, targets it for Targeted Protein Degradation. This connection between protein targeting and protein quality control is critical: a protein that fails to fold properly is often degraded rather than allowed to accumulate.

How Do Cells Know Where to Send a Protein?

The specificity of protein targeting lies in the signal sequences and the receptors that recognize them. Different organelles use different "address codes," and these codes are recognized by distinct receptors.

Signal Peptides and Their Cleavage

ER signal peptides are cleaved by signal peptidase, a membrane-bound enzyme on the lumenal side of the ER. The cleavage site is typically after a small, neutral amino acid (alanine, glycine, serine) at position −1 relative to the cleavage site, with a similar residue at position −3. This "−3, −1 rule" is used to predict signal peptide cleavage sites computationally.

After cleavage, the signal peptide is further degraded by signal peptide peptidase. The mature protein, now lacking its signal sequence, is free to fold and proceed through the secretory pathway.

Mitochondrial targeting signals are also cleaved, but by a different enzyme: mitochondrial processing peptidase (MPP) in the matrix. Some mitochondrial proteins undergo two-step cleavage, with an intermediate processing peptidase removing a second signal that directs the protein to the intermembrane space.

Nuclear Localization Signals (NLS)

Nuclear localization signals are not cleaved after import. They remain part of the mature protein, allowing the protein to be re-imported after cell division when the nuclear envelope breaks down and reforms.

The classical NLS consists of one or two stretches of basic amino acids. The SV40 large T antigen NLS is the sequence PKKKRKV; nucleoplasmin has a bipartite NLS with two basic clusters separated by a spacer of about 10 amino acids. These signals are recognized by importin α, which binds the NLS and links to importin β, which mediates translocation through the nuclear pore complex.

Mitochondrial Targeting Signals

Mitochondrial targeting signals are typically 20–40 amino acids long, rich in arginine and lysine, and lacking acidic residues. They form an amphipathic α-helix—one face positively charged, the other hydrophobic. This helix is recognized by Tom20 on the mitochondrial surface.

The signal is cleaved by mitochondrial processing peptidase in the matrix. For proteins destined for the inner membrane or intermembrane space, additional sorting signals direct them to their final location. Some proteins destined for the outer membrane contain internal signals rather than N-terminal presequences.

Methods Used to Study Protein Targeting

Understanding protein targeting has required the development of sophisticated experimental techniques. These methods allow researchers to visualize protein movement in living cells, track the timing of targeting events, and identify the genes required for the process.

Fluorescent Protein Tagging

The discovery and engineering of green fluorescent protein (GFP) from the jellyfish Aequorea victoria revolutionized the study of protein localization. By fusing GFP to a protein of interest, researchers can visualize its location in living cells using fluorescence microscopy.

This technique has been refined with the development of photoactivatable GFP, which can be switched on by a pulse of light. By photoactivating a pool of protein in one location and watching where it moves over time, researchers can track protein trafficking in real time. Fluorescence recovery after photobleaching (FRAP) is another variant: a region is photobleached, and the rate at which fluorescence recovers indicates how quickly new protein moves into that region.

Pulse-Chase Experiments

Pulse-chase experiments track the movement of proteins over time. Cells are briefly exposed to a radioactive or fluorescent amino acid (the pulse), which is incorporated into newly synthesized proteins. The label is then removed and replaced with excess unlabeled amino acid (the chase). At various time points, cells are lysed, and the labeled protein is detected by immunoprecipitation or autoradiography.

This technique was used classically to demonstrate that secretory proteins pass through the ER and Golgi before reaching the cell surface. By following the label over time, researchers could show that a protein first appears in the ER, then in the Golgi, and finally in secretory vesicles.

Genetic Screens for Targeting Mutants

Genetic screens have identified the genes required for protein targeting. In the yeast Saccharomyces cerevisiae, temperature-sensitive mutants that fail to secrete proteins at the restrictive temperature were isolated. These sec mutants define the secretory pathway: sec61 mutants block ER translocation, sec13 and sec23 mutants block ER-to-Golgi transport, and sec7 mutants block Golgi function.

Similar screens in mitochondria have identified tom and tim mutants that fail to import mitochondrial proteins. These screens have revealed the full complement of proteins required for targeting and have shown that the machinery is conserved from yeast to humans.

Common Pitfalls and Misconceptions

Students learning about protein targeting often encounter several conceptual difficulties. Understanding these pitfalls can help clarify the material.

Misunderstanding Signal Sequences

A common misconception is that signal sequences are always at the N-terminus and always cleaved. In reality, signal sequences can be internal (as in peroxisomal targeting signals) or at the C-terminus (as in some peroxisomal matrix proteins). Nuclear localization signals are never cleaved, and some ER membrane proteins contain internal signal sequences that serve as both targeting signals and membrane anchors.

Another misconception is that the signal sequence alone determines the destination. In fact, the context matters: a signal sequence can be recognized differently depending on the protein's folding state, the presence of other targeting signals, and the cell type. Some proteins contain multiple targeting signals with different strengths, and the final localization depends on which signal dominates.

Overlooking Post-Translational Targeting

Many students assume that all protein targeting occurs co-translationally. In reality, a large fraction of cellular proteins are targeted post-translationally. Mitochondrial proteins, chloroplast proteins, peroxisomal proteins, and nuclear proteins are all imported after complete synthesis in the cytosol. Even some ER-destined proteins in yeast can be imported post-translationally, using a different translocon complex (Sec62/Sec63) that works with BiP to pull the protein into the ER.

Assuming All Proteins Are Secreted

Another common error is assuming that all proteins synthesized on bound ribosomes are secreted. In fact, the ER is the entry point for many different destinations: the ER itself, the Golgi, lysosomes, the plasma membrane, and the extracellular space. Proteins destined for each of these locations contain additional sorting signals that direct them to their final destination. For example, lysosomal enzymes are tagged with mannose-6-phosphate in the Golgi, and this tag is recognized by receptors that package the enzymes into vesicles destined for lysosomes.

Frequently Asked Questions

What is protein targeting?

Protein targeting is the process by which cells direct newly synthesized proteins to their correct subcellular locations. It involves signal sequences on the protein, receptors that recognize those signals, and translocation machinery that moves the protein across or into the target membrane.

Why is protein targeting important?

Protein targeting is essential for cellular organization and function. Each cellular compartment requires a specific set of proteins to perform its functions. Errors in targeting cause disease, including cystic fibrosis, certain metabolic disorders, and some neurodegenerative conditions.

What are the types of protein targeting?

Protein targeting is divided into co-translational targeting (which occurs during translation, primarily to the ER) and post-translational targeting (which occurs after translation is complete, to mitochondria, chloroplasts, peroxisomes, and the nucleus).

How does a protein know where to go?

Proteins contain signal sequences—short stretches of amino acids that function as molecular address tags. These sequences are recognized by specific receptors that direct the protein to its destination. The signal sequence is like a zip code that tells the cell where the protein belongs.

What is a signal sequence?

A signal sequence is a short (typically 15–40 amino acid) stretch of amino acids that directs a protein to a specific cellular location. Different organelles use different signal sequences: ER signal sequences have a hydrophobic core, mitochondrial signals are rich in basic amino acids, and nuclear localization signals contain clusters of lysine and arginine.

What is the role of the signal recognition particle (SRP)?

The signal recognition particle is a ribonucleoprotein complex that recognizes ER signal sequences as they emerge from the ribosome. SRP binds the signal sequence, pauses translation, and delivers the ribosome–nascent chain complex to the ER membrane, where it interacts with the SRP receptor and transfers the nascent chain to the translocon.

Can protein targeting go wrong?

Yes. Mutations in signal sequences can cause proteins to be delivered to the wrong location. Mutations in targeting machinery can block import entirely. Misfolded proteins may be retained in the ER and targeted for degradation. These errors cause diseases such as cystic fibrosis, primary hyperoxaluria, and certain forms of cardiomyopathy.

How is protein targeting studied?

Protein targeting is studied using fluorescent protein tagging and live-cell microscopy, pulse-chase experiments to track protein movement over time, genetic screens to identify targeting factors, and biochemical assays to reconstitute import in vitro.

Key Takeaways

Protein targeting is the process by which cells direct proteins to their correct subcellular destinations, essential for cellular function and organization.
Proteins contain signal sequences—molecular zip codes—that are recognized by receptors and direct the protein to its target organelle.
Co-translational targeting delivers proteins to the ER during translation, while post-translational targeting delivers proteins to mitochondria, chloroplasts, peroxisomes, and the nucleus after synthesis is complete.
The molecular machinery includes SRP and its receptor for ER targeting, TOM/TIM complexes for mitochondria, and importins for nuclear import.
Signal sequences are often cleaved after import, but some (like nuclear localization signals) remain part of the mature protein.
Chaperones assist in protein folding after translocation, and misfolded proteins are degraded rather than allowed to accumulate.
Defects in protein targeting cause human diseases, making this process a critical area of biomedical research.